ESPE Abstracts
Scientific Programme, ePosters & Abstracts
Menu
Search
Issues/Conferences
Cite
Contact
Disclaimer
Search
Issues/Conferences
Cite
Contact
Disclaimer
Previous issue
|
Volume 98
|
ESPE2024
62nd Annual ESPE (ESPE 2024)
Liverpool,
UK
16 Nov 2024 - 18 Nov 2024
All volumes
0098 ESPE2024
0097 ESPE2023
0095 ESPE2022
0094 ESPE2021
0092 ESPE2019
0089 ESPE2018
0086 ESPE2016
0084 ESPE2015
0082 ESPE2014
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.
Summary
Abstracts
Contents
Plenary Lectures
Impact of GH treatment on DNA damage
Impact of GH on DNA Damage
hrp0098pl1
Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Abstract unavailable
hrp0098pl2
Precision medicine in monogenic obesity
Abstract unavailable
hrp0098pl3
The importance of chronobiology for medicine – when time matters
Abstract unavailable
hrp0098pl4
MKRN3 and the initiation of puberty
MKRN3 and the initiation of puberty
hrp0098pl5
Pancreatic and islet plasticity in early life: implications for diabetes risk
Abstract unavailable
hrp0098pl6
Fat & Bone; where are we now?
Bone and Fat: Where are We Now?
hrp0098pl7
Genomics in Rare Diseases
Abstract unavailable
hrp0098pl8
Symposia
Disorders of Sex Development: Novel advances in management
Abstract unavailable
hrp0098s1.1
Novel mechanisms leading to DSD (genomic, digenic/oligogenic and non-coding variation)
hrp0098s1.2
Hypospadias- surgery and beyond
hrp0098s1.3
Bone and Mineral Disorders: Recent Developments
Phosphate sensing in normal physiology and disease
hrp0098s2.1
Abstract unavailable
hrp0098s2.2
PTH Resistance Syndromes
hrp0098s2.3
Novel Advances in the Treatment of Hypothalamic disease
Abstract unavailable
hrp0098s3.1
Use of MC4R agonist in hypothalamic obesity
hrp0098s3.2
Abstract unavailable
hrp0098s3.3
New Adjuvant Therapy in Pediatric Diabetes (Joint ISPAD‐ESPE Symposium)
Use of Verapamil in newly diagnosed T1D
hrp0098s4.1
Abstract unavailable
hrp0098s4.2
Statins and cardiovascular risk in type 1 diabetes
hrp0098s4.3
Adrenal Disorders
Innovations in pharmacotherapy for congenital adrenal hyperplasia
hrp0098s5.1
Translational Clinical Applications of Complex Steroidobolome Data
hrp0098s5.2
Lessons from CAH service evaluation and real-world data
hrp0098s5.3
Novel Insights into Pituitary Disorders
Abstract unavailable
hrp0098s6.1
Early postnatal pituitary stem cells mostly generate gonadotrophs
hrp0098s6.2
Management of idiopathic pituitary stalk thickening
hrp0098s6.3
Future hope for skeletal disorders
Stem cells in skeletal development and growth
hrp0098s7.1
Abstract unavailable
hrp0098s7.2
Consensus statement on management of achondroplasia
hrp0098s7.3
Improving treatment strategies in Obesity
Pharmacotherapy of Obesity
hrp0098s8.1
The Impact of Adolescent Overweight and Obesity on Adult Morbidity and Mortality
hrp0098s8.2
Bariatric Surgery: Impact Beyond Weight Loss
hrp0098s8.3
Novel advances in paediatric thyroid disease
Genetics of congenital hypothyroidism: Modern concepts
hrp0098s9.1
Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
hrp0098s9.2
Abstract unavailable
hrp0098s9.3
Challenges in the management of Prader Willi Syndrome
Abstract unavailable
hrp0098s10.1
Abstract unavailable
hrp0098s10.2
Growth hormone treatment in adults with PWS
hrp0098s10.3
Microbiota in type 1 diabetes
Gut dysbiosis in type 1 diabetes
hrp0098s11.1
Abstract unavailable
hrp0098s11.2
Abstract unavailable
hrp0098s11.3
The impact of gonadotrophin dysregulation on neurocognition
The Role of MiniPuberty in Non-Reproductive Outcomes
hrp0098s12.1
Neurodevelopmental syndromes associated with central precocious puberty
hrp0098s12.2
Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining
in silico
,
in vitro
and
in vivo
tools
hrp0098s12.3
Meet the Expert
Genetic Testing in Hypogonadism
Abstract unavailable
hrp0098mte1
Management of Lipodystrophy
Abstract unavailable
hrp0098mte2
Pharmacological treatment options for adolescents with Obesity
Abstract unavailable
hrp0098mte3
Closed loop in the very young child with Type 1 Diabetes
Abstract unavailable
hrp0098mte4
Managing difficult menstrual periods
Abstract unavailable
hrp0098mte5
Management of sodium and water regulation disorders
Abstract unavailable
hrp0098mte6
Diagnosis and Management of PCOS
Abstract unavailable
hrp0098mte7
The Diagnosis & Management of Rickets in the 21st Century
Abstract unavailable
hrp0098mte8
How Do I…
How Do I… Session 1
Abstract unavailable
hrp0098hdi1.1
Abstract unavailable
hrp0098hdi1.2
How do I... Manage the infant with hypoglycaemia
hrp0098hdi1.3
How Do I… Session 2
Abstract unavailable
hrp0098hdi2.1
Abstract unavailable
hrp0098hdi2.2
Abstract unavailable
hrp0098hdi2.3
Controversies
Should we restrict height in tall stature?
Controversy: Should we restrict height in tall stature?
hrp0098con1
Novel Advances
Novel Advances Session
Abstract unavailable
hrp0098na1
Young Investigators
Section
Abstract unavailable
hrp0098yi1.1
Abstract unavailable
hrp0098yi1.2
Abstract unavailable
hrp0098yi1.3
Working Group Symposia
ESPE Working Group on Obesity
Abstract unavailable
hrp0098wg1.1
Abstract unavailable
hrp0098wg1.2
Abstract unavailable
hrp0098wg1.3
Abstract unavailable
hrp0098wg1.4
ESPE Working Group on Gender Incongruence
Immunological effects of gender-affirming hormone treatment
hrp0098wg2.1
Abstract unavailable
hrp0098wg2.2
Abstract unavailable
hrp0098wg2.3
ESPE Working Group on Paediatric and Adolescent Gynaecology
Abstract unavailable
hrp0098wg3.1
Abstract unavailable
hrp0098wg3.2
Fertility preservation in girls
hrp0098wg3.3
ESPE Working Group on Turner Syndrome
Abstract unavailable
hrp0098wg4.1
Beyond growth and puberty – monitoring co-morbidities in Turner syndrome
hrp0098wg4.2
Turner syndrome and care during adulthood
hrp0098wg4.3
Abstract unavailable
hrp0098wg4.4
Abstract unavailable
hrp0098wg4.5
ESPE Working Group on Bone and Growth Plate
Abstract unavailable
hrp0098wg5.1
Abstract unavailable
hrp0098wg5.2
Abstract unavailable
hrp0098wg5.3
ESPE Working Group on Gender Dysphoria (GD) Symposium
Abstract unavailable
hrp0098wg6.1
Abstract unavailable
hrp0098wg6.2
Abstract unavailable
hrp0098wg6.3
ESPE Working Group for Paediatric Endocrine Nurses
Abstract unavailable
hrp0098wg7.1
Abstract unavailable
hrp0098wg7.2
Abstract unavailable
hrp0098wg7.3
ESPE Working Group on Disorders/Differences of Sex Development
Abstract unavailable
hrp0098wg8.1
Abstract unavailable
hrp0098wg8.2
Endo‐ERN Symposium
Section
Abstract unavailable
hrp0098ee1.1
Abstract unavailable
hrp0098ee1.2
Genetic testing in rare forms of primary adrenal insufficiency
hrp0098ee1.3
The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
hrp0098ee1.4
ESPE‐ESE Joint Symposium
Section
Abstract unavailable
hrp0098es1.1
Prenatal Exposure to Over-the-Counter Antifungal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
hrp0098es1.2
Abstract unavailable
hrp0098es1.3
ESPE Yearbook Sessions
Year of Paediatric Endocrinology 1
Abstract unavailable
hrp0098yb1.1
Abstract unavailable
hrp0098yb1.2
Abstract unavailable
hrp0098yb1.3
Abstract unavailable
hrp0098yb1.4
Abstract unavailable
hrp0098yb1.5
Year of Paediatric Endocrinology 2
Abstract unavailable
hrp0098yb2.1
Abstract unavailable
hrp0098yb2.2
Abstract unavailable
hrp0098yb2.3
Abstract unavailable
hrp0098yb2.4
Abstract unavailable
hrp0098yb2.5
Year of Paediatric Endocrinology 3
Abstract unavailable
hrp0098yb3.1
Abstract unavailable
hrp0098yb3.2
Abstract unavailable
hrp0098yb3.3
Abstract unavailable
hrp0098yb3.4
Abstract unavailable
hrp0098yb3.5
Henning Andersen Award Winners
Biallelic missense FDX1 mutation causes congenital adrenal hyperplasia with 11β‐hydroxylase deficiency and vitamin D‐resistant bone rickets
Biallelic missense
FDX1
mutation causes congenital adrenal hyperplasia with 11β-hydroxylase deficiency and vitamin D-resistant bone rickets
hrp0098ha1
A novel human disorder: QSOX2 deficiency‐induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease.
A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease
hrp0098ha2
Free Communications
Diabetes and Insulin
Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
hrp0098fc1.1
Effect of hydroxychloroquine therapy in newly diagnosed type 1 diabetes: a randomised, double-blind, placebo-control pilot trial
hrp0098fc1.2
A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
hrp0098fc1.3
A personalized approach to classify the degree of liver insulin resistance in children with obesity
hrp0098fc1.4
The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
hrp0098fc1.5
Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
hrp0098fc1.6
Bone, Growth Plate and Mineral Metabolism
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
hrp0098fc2.1
Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis:
In Vitro
Model
hrp0098fc2.2
Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
hrp0098fc2.3
Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
hrp0098fc2.4
Bone health in adolescents with cow’s milk allergy during infancy
hrp0098fc2.5
Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
hrp0098fc2.6
Pituitary, Neuroendocrinology and Puberty 1
The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
hrp0098fc3.1
Disruption of the Wnt-antagonist
APC
in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
hrp0098fc3.2
Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood onset craniopharyngioma
hrp0098fc3.3
The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers
hrp0098fc3.4
Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
hrp0098fc3.5
Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
hrp0098fc3.6
Adrenals and HPA Axis 1
Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH)
hrp0098fc4.1
11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in
ex vivo
culture
hrp0098fc4.2
Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
hrp0098fc4.3
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF
1
) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst
TM
Pediatric
hrp0098fc4.4
3D printed, personalized hydrocortisone for hypocortisolemia
hrp0098fc4.5
Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
hrp0098fc4.6
Growth and Syndromes
A homozygous variant in
ZSWIM6
causes short stature, microcephaly and developmental delay
hrp0098fc5.1
The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
hrp0098fc5.2
Gene expression of monosomy × during human development reveals potential mechanisms in Turner syndrome
hrp0098fc5.3
Predictors of short stature at age 6-7 years in Israeli children
hrp0098fc5.4
Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
hrp0098fc5.5
First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex
®
Registry
hrp0098fc5.6
Fat, Metabolism and Obesity 1
Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
hrp0098fc6.1
Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
hrp0098fc6.2
SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
hrp0098fc6.3
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
hrp0098fc6.4
First cross sectional analysis of the eclip registry
hrp0098fc6.5
Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
hrp0098fc6.6
GH and IGFs
Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
hrp0098fc7.1
Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
hrp0098fc7.2
Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
hrp0098fc7.3
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
hrp0098fc7.4
Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
hrp0098fc7.5
Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
hrp0098fc7.6
Adrenals and HPA Axis 2
Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
hrp0098fc8.1
Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
hrp0098fc8.2
Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
hrp0098fc8.3
A deep intronic splice variant of
CYP11B1
is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
hrp0098fc8.4
Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
hrp0098fc8.5
Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
hrp0098fc8.6
Sex Endocrinology and Gonads
A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
hrp0098fc9.1
Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
hrp0098fc9.2
Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
hrp0098fc9.3
Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
hrp0098fc9.4
Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
hrp0098fc9.5
The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
hrp0098fc9.6
Multisystem Endocrine Disorders
Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
hrp0098fc10.1
Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918T
RET
pathogenic variants in children and young people
hrp0098fc10.2
Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
hrp0098fc10.3
A novel
de novo SAMD9
gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male
hrp0098fc10.4
Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
hrp0098fc10.5
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
hrp0098fc10.6
Fat, Metabolism and Obesity 2
Frequency of rare syndromic diseases in a population with early-onset obesity
hrp0098fc11.1
Frequency of rare non-syndromic diseases in a population with early-onset obesity
hrp0098fc11.2
Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
hrp0098fc11.3
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
hrp0098fc11.4
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
hrp0098fc11.5
Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
hrp0098fc11.6
Thyroid
Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
hrp0098fc12.1
Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
hrp0098fc12.2
Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
hrp0098fc12.3
Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
hrp0098fc12.4
The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
hrp0098fc12.5
The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency
hrp0098fc12.6
Pituitary, Neuroendocrinology and Puberty 2
Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
hrp0098fc13.1
Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
hrp0098fc13.2
Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
hrp0098fc13.3
Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
hrp0098fc13.4
Rising in body mass index during childhood in girls with idiopathic CPP: a 20-year experience in a tertiary Belgian centre
hrp0098fc13.5
Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
hrp0098fc13.6
Fetal and Neonatal Endocrinology
Non-invasive prenatal testing can detect maternally and paternally inherited variants in the
KCNJ11
and
ABCC8
genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
hrp0098fc14.1
Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism
hrp0098fc14.2
Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
hrp0098fc14.3
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
hrp0098fc14.4
A novel 94bp deletion in the
SLC16A1
promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
hrp0098fc14.5
Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
hrp0098fc14.6
Late Breaking
Response to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
hrp0098fc15.1
Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
hrp0098fc15.2
Assessment of actionable secondary genetic findings in a large cohort of children with short stature
hrp0098fc15.3
Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
hrp0098fc15.4
Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
hrp0098fc15.5
Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
hrp0098fc15.6
Rapid Free Communications
Diabetes and Insulin
Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
hrp0098rfc1.1
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus
hrp0098rfc1.2
Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression
hrp0098rfc1.3
Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
hrp0098rfc1.4
Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
hrp0098rfc1.5
Metabolic dysfunction-associated steatotic liver disease and its association with glycemic control metrics in children and adolescents with type 1 diabetes: an exploratory study
hrp0098rfc1.6
Bone, Growth Plate and Mineral Metabolism
Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study
hrp0098rfc2.1
Microarchitectural Alterations in Children with Rheumatological conditions on Long term Glucocorticoid Treatment
hrp0098rfc2.2
Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
hrp0098rfc2.3
CYP24A1 mutations: clinical and laboratory features in patients presenting with hypercalcemia
hrp0098rfc2.4
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
hrp0098rfc2.5
Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
hrp0098rfc2.6
Pituitary, Neuroendocrinology and Puberty 1
DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
hrp0098rfc3.1
Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance
hrp0098rfc3.2
Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
hrp0098rfc3.3
Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
hrp0098rfc3.4
Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
hrp0098rfc3.5
Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
hrp0098rfc3.6
Adrenals and HPA Axis 1
Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
hrp0098rfc4.1
Salivary cortisol and cortisone is related to age
hrp0098rfc4.2
Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
hrp0098rfc4.3
Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
hrp0098rfc4.4
Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
hrp0098rfc4.5
Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
hrp0098rfc4.6
Growth and Syndromes
About caring for patients and understanding their pathways: 10 years of ‘the rotterdam centre for adults with rare genetic syndromes’
hrp0098rfc5.1
The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders
hrp0098rfc5.2
Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
hrp0098rfc5.3
Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
hrp0098rfc5.4
Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
hrp0098rfc5.5
Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
hrp0098rfc5.6
Fat, Metabolism and Obesity 1
Frequency of genetic variants in a population with early-onset obesity: a single center experience
hrp0098rfc6.1
Genetic Diagnostic Yield of Obesity
hrp0098rfc6.2
Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
hrp0098rfc6.3
Investigation of
GNAS
Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing
In Silico
,
In Vivo
, and
In Vitro
Studies
hrp0098rfc6.4
GRB10 methylation in umbilical cord associates postnatally with obesity in healthy children
hrp0098rfc6.5
Potential role of
aspg
methylation as a biomarker of childhood obesity
hrp0098rfc6.6
GH and IGFs
Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
hrp0098rfc7.1
Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
hrp0098rfc7.2
Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
hrp0098rfc7.3
Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficienc
hrp0098rfc7.4
Health-related quality of life at mid-puberty in adolescents with idiopathic isolated growth hormone deficiency
hrp0098rfc7.5
Big data as a strategy in the development of population auxological studies
hrp0098rfc7.6
Adrenals and HPA Axis 2
Predict – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
hrp0098rfc8.1
A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations
hrp0098rfc8.2
Multi-hit Model of Primary Adrenal Insufficiency in
CPOX mutations
hrp0098rfc8.3
Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization of a Large Sudanese Cohort
hrp0098rfc8.4
Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
hrp0098rfc8.5
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH)
hrp0098rfc8.6
Sex Endocrinology and Gonads
Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
hrp0098rfc9.1
Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
hrp0098rfc9.2
Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS
hrp0098rfc9.3
Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
hrp0098rfc9.4
Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
hrp0098rfc9.5
GnRHa treatment of cryptorchidism alters testicular sumo gene expression
hrp0098rfc9.6
Multisystem Endocrine Disorders
Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
hrp0098rfc10.1
Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
hrp0098rfc10.2
Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center
hrp0098rfc10.3
Manifestation of PTEN and MUTYH gene mutations: A Case Report
hrp0098rfc10.4
GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
hrp0098rfc10.5
Different Faces of Carney Complex: Report of Three Cases
hrp0098rfc10.6
Fat, Metabolism and Obesity 2
Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
hrp0098rfc11.1
Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
hrp0098rfc11.2
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
hrp0098rfc11.3
Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
hrp0098rfc11.4
Hepatic lipogenesis increases FGF21 in children/adolescents with obesity
hrp0098rfc11.5
Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
hrp0098rfc11.6
Thyroid
From neurology to endocrine: Misdiagnosed MCT8 deficiency
hrp0098rfc12.1
Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
hrp0098rfc12.2
Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
hrp0098rfc12.3
Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
hrp0098rfc12.4
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
hrp0098rfc12.5
Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
hrp0098rfc12.6
Pituitary, Neuroendocrinology and Puberty 2
MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
hrp0098rfc13.1
Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes
hrp0098rfc13.2
Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders
hrp0098rfc13.3
Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
hrp0098rfc13.4
The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
hrp0098rfc13.5
Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
hrp0098rfc13.6
Fetal and Neonatal Endocrinology
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life
hrp0098rfc14.1
Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
hrp0098rfc14.2
Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
hrp0098rfc14.3
Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant
hrp0098rfc14.4
The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation
hrp0098rfc14.5
Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
hrp0098rfc14.6
Late Breaking
Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism
hrp0098rfc15.1
Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
hrp0098rfc15.2
The different faces of acquired hypothalamic dysfunction
hrp0098rfc15.3
Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
hrp0098rfc15.4
Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
hrp0098rfc15.5
Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation
hrp0098rfc15.6
Top 20 Posters
Top 20 Posters
Genetic and Nutritional Influences on Growth: A Case of PAPPA2-Related Growth Disorder in a Pediatric Patient
hrp0098t1
Comprehensive Evaluation of Anastrozole in Pediatric Height Management and Bone Health– A Real World Data
hrp0098t2
Development and Validation of DSD Interpreter, a Mobile Application-Based Tool for Point-of-Care evaluation of Children with Atypical Genitalia
hrp0098t3
More than 15 years of activity of the Ghent pediatric gender service: trends in referrals and medical steps
hrp0098t4
Endocrine and metabolic complications after solid organ transplantation in childhood and adolescents
hrp0098t5
Gonadal function in patients with germline variants of WT1: results from the French GONADVENIR’s retrospective study
hrp0098t6
Long-read sequencing analysis in two Beckwith-Wiedemann syndrome families caused by defects of OCT4/SOX2 binding site
hrp0098t7
Predicting the risk of fragility fractures in childhood hematologic cancer survivors
hrp0098t8
Differential microRNA Expression Profiles in Girls with Central Precocious Puberty and Premature Thelarche
hrp0098t9
Phenotypic and genotypic characterization and long-term follow-up of patients with thyroid hormone resistance
hrp0098t10
Postnatal detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction – potential for newborn screening
hrp0098t11
Investigating the Effects of Familial Mediterranean Fever on Growth and Puberty: Does the Duration of Puberty Change?
hrp0098t12
Differential Impact of Maternal and Paternal Metabolic Syndrome on Offspring’s Cardiometabolic Risk Factors
hrp0098t13
Alterations in BMI and Body Composition Twelve Months After Cessation of Growth Hormone Therapy in Adolescents with Prader-Willi Syndrome (PWS)
hrp0098t15
The importance of genetic diagnosis in obesity - leptin-melanocortin pathway and beyond
hrp0098t16
Burden of disease across age groups in individuals with hereditary hypophosphatemia – a retrospective Danish register study
hrp0098t17
DNA methylation level at five specific CG-sites within TRAK1 correlates with the neurocognitive profile in individuals with Klinefelter syndrome
hrp0098t18
Ultrasonographic Evaluation of Ovarian and Uterine Morphology in Minipuberty and Associations with Reproductive Hormones: A COPANA Cohort Study of 302 infant girls
hrp0098t19
Real World Effectiveness of Vosoritide in 165 Children with Achondroplasia – Data from a Multicenter European Registry
hrp0098t20
Poster Category 1
Adrenals and HPA Axis 1
Growth-promoting effect of adjuvant treatment in classic CAH 21OHD with impaired growth potential
hrp0098p1-1
Reciprocal regulation of 11b-HSD1/2 correlates initial glucocorticoids responsiveness in childhood acute lymphoblastic leukemia
hrp0098p1-2
Insulin-induced copeptin response in children and adolescents to diagnose arginine vasopressin deficiency* (*partly presented at the 61st Annual ESPE Meeting 2023)
hrp0098p1-3
The Role of Endogenous Opioids (EOPs) in Ischaemic Pre-Conditioning (IPC) in Humans
hrp0098p1-4
Evaluation of 2 years second tier testing for the screening on congenital adrenal hyperplasia (CAH)
hrp0098p1-5
Impact of Fludrocortisone on Blood Pressure in Young Children Under 5 with CAH in the I-CAH Registry: Autoregressive Causal Inference Analysis
hrp0098p1-6
Variation in Blood Pressure in Young Adults with 21a-Hydroxylase Deficiency: Longitudinal Multilevel Modelling of Data from the I-CAH Registry
hrp0098p1-7
Leptin and adiponectin are associated with the glucocorticoid dose and androgen concentrations in children and young persons with congenital adrenal hyperplasia: data from the CAH-UK cohort
hrp0098p1-8
Exploring the Long-Term Consequences of Congenital Adrenal Hyperplasia: First Study of Testicular Adrenal Rest Tumors Profile in Indonesia
hrp0098p1-9
Bone, Growth Plate and Mineral Metabolism 1
Causality between Sex Hormones and Bone Mineral Density in Childhood: Age- and Tanner stage-matched Sex Hormone Level May be an Early Interpreter of Pediatric Bone Fragility
hrp0098p1-10
Clinical and genetic characteristics of primary hypoparathyroidism in children a multicenter experience in China
hrp0098p1-11
X-linked hypophosphatemia caused by a novel deep intronic variant in the
PHEX
gene
hrp0098p1-12
The Prevalence and Genotype-phenotype Correlation of Type E Brachydactyly in Chinese Children
hrp0098p1-13
A Pilot Study on the Prevalence and Genetic Spectrum of Hypophosphatasia in Suzhou
hrp0098p1-14
Adipokines level and vertebral fracture in children and adolescent with systemic lupus erythematous receiving glucocorticoid therapy
hrp0098p1-15
A rare case of XLH with poor response to Burosumab:
PHEX
and
SLC34A1
gene mutations
hrp0098p1-16
New clinical phenotypes associated with ALPL mutations
hrp0098p1-17
Vosoritide therapy in 16 young children with achondroplasia: a retrospective study
hrp0098p1-18
Autosomal Dominant Hypocalcemia type 1 (ADH 1) with hypercalciuria due to CASR Ser820Phe mutation: a case report
hrp0098p1-19
Cross-talk between mechanical loading and longitudinal bone growth under chronic inflammation
hrp0098p1-20
Diabetes and Insulin 1
A population preventive study of early detection of type 1 diabetes in asymptomatic children in the North-East region of Poland
hrp0098p1-21
Clinical and molecular spectrum of polycystic kidney syndrome and diabetes due tomutations in hnf-1b
hrp0098p1-22
Liraglutide potently protects against streptozotocin-induced acute islet injury by inhibiting HMGB1 release
hrp0098p1-23
Associations between arterial stiffness and metabolic target in children and adolescents with type 1 diabetes treated in a modern setting
hrp0098p1-24
Assessment of small nerve fiber function as an early marker of peripheral neuropathy in children and adolescents with type 1 diabetes mellitus (T1DM)
hrp0098p1-25
Exercise induced hyperinsulinism as a rare cause of hypoglycaemia: A case report
hrp0098p1-26
Insights into the Application of Molecular Genetics for Early Onset Diabetes Mellitus in a Prospective Pediatric Study
hrp0098p1-27
Role of urinary tumor necrosis factor-alpha and transferrin in the diagnosis of diabetic nephropathy in pediatric patients with type 1 diabetes mellitus
hrp0098p1-28
Wolcott-Rallison Syndrome: A Case Report of Novel Mutation
hrp0098p1-29
Diabetes and Insulin 2
The Impact of Sleep Quality and Metabolic Control in Children with Type 1 Diabetes: a Prospective Cohort Study
hrp0098p1-30
Rare forms of (non)syndromic monogenic diabetes in the Czech registry of patients susceptible for monogenic diabetes
hrp0098p1-31
Factors Associated with Pump Set Occlusion
hrp0098p1-32
A Case of Mild Clinical Course MODY9
hrp0098p1-33
Sexual knowledge and contraceptive use in adolescents with type 1 diabetes in comparison with their healthy peers
hrp0098p1-34
Diabetes Mellitus in Woodhouse -Sakati syndrome
hrp0098p1-35
Hair proteomics profile in girls with newly-diagnosed type 1 diabetes mellitus
hrp0098p1-36
Influence of type 1 diabetes on age of menarche in girls with type 1 diabetes
hrp0098p1-37
A Retrospective Analysis of Cost of Admission Care in Children with First Presentation of T1D at University Hospital Limerick: Assessing the Feasibility of Ambulatory Care
hrp0098p1-38
Fat, Metabolism and Obesity 1
The Effect of Excessive Fructose (Corn Syrup) Consumption on Insulin resistance, Lipid Profile and Lipid Peroxidation
hrp0098p1-39
Detection of risk of non-alcoholic hepatic steatosis (nash) in obese children's population through rapid ultrasound measurement of preperitoneral abdominal fat “at the bed side”. a new strategy
hrp0098p1-40
Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with non-alcoholic fatty liver disease
hrp0098p1-41
Unravelling the relationship between Head Circumference and Melanocortin4-Receptor deficiency from infancy to adulthood: a case-control study
hrp0098p1-42
BIO-STREAMS: Multi-Pillar Framework for children Anti-Obesity Behavior building on an EU biobank, Micro Moments and Mobile Recommendation Systems
hrp0098p1-43
Assessment of metabolomic-nutritional status and cardiovascular risk in adolescents with anorexia nervosa and low body weight
hrp0098p1-44
EARLIE – Pilot study for universal familial hypercholesterolemia screening in Luxembourgish primary school children
hrp0098p1-45
Circulating levels of ghrelin in patients with a rare disease with intellectual disability associated with hyperphagia, and/or overweight, and/or obesity – The HOGRID study
hrp0098p1-46
Sleep quality and telomere length after long-term impact of a lifestyle intervention in patients with abdominal obesity
hrp0098p1-47
Relationship between serum and faecal zonulin concentration and glucidic metabolism in children and adolescents with obesity
hrp0098p1-48
GH and IGFs 1
Correlations Between Nutritional Interventions, Growth Dynamics, and IGF-1 Levels in Pediatric Populations: A Comprehensive Analysis
hrp0098p1-49
Genetic Variations in IGF1R and IGF1: Elucidating Their Role in Growth Disorders and Therapeutic Responsiveness
hrp0098p1-50
The Metabolic Impacts of GH Therapy in SGA Children and Its Effects on Various Metabolic Parameters and Health Outcomes
hrp0098p1-51
Changes in Length and Weight Standard Deviation Scores in Children with Growth Hormone Deficiency Across Various Studies
hrp0098p1-52
Correlation of Growth Hormone Secretion and Infantile Growth Patterns in Children Diagnosed with Growth Hormone Deficiency (GHD)
hrp0098p1-53
Should MRI Be Performed on the Pituitary Gland in Short Stature Children with Peak Growth Hormone Levels Between 5 and 7 Micrograms/Liter Following Provocation Tests?"
hrp0098p1-54
The Relation Between Serum Glucose and Growth Hormone Concentrations During Standard Glucagon Test for GH Release in Short Stature Children
hrp0098p1-55
Body composition abnormalities during the transition stage in males with growth hormone deficiency (GHD) after completion of replacement therapy
hrp0098p1-56
Long-term treatment with recombinant human growth hormone in pediatric patients influences but does not destroy stem cells circulating in peripheral blood
hrp0098p1-57
Somapacitan is Effective and Well Tolerated in Chinese Children with GHD: 52-week Results from the Randomized Phase 3 REAL6 Trial
hrp0098p1-58
Near adult height in prepubertal children treated with growth hormone: differences between definite growth hormone deficiency (dGHD), short stature unresponsive to stimulation tests (SUS) and idiopathic short stature (ISS)
hrp0098p1-59
Growth and Syndromes 1
Big data tools for assessing the nutritional situation of a pediatric population: did the prevalence of obesity change pre- and post-pandemic?
hrp0098p1-60
Comparison of the diagnostic yield of whole exome sequencing (WES) and targeted panel sequencing for children with idiopathic short stature (ISS)
hrp0098p1-61
Aromatase inhibitors combined with rhGH treatment for idiopathic short stature in male adolescents Letrozole vs Anastrozole
hrp0098p1-62
Long-term effectiveness and safety data from the Global Increlex
®
Registry in patients treated with rhIGF-1: Subgroup analysis of naïve pre-pubertal patients and patients with Laron syndrome
hrp0098p1-63
Osteocalcin in infancy and early childhood correlates to growth and body composition: A longitudinal birth cohort study
hrp0098p1-64
Cardiovascular autonomic dysfunction and sleep abnormalities in children with Prader-Willi syndrome
hrp0098p1-65
Turner Syndrome Across Karyotypes: The importance of the short arm of the X chromosome and Neutrophil-Driven Inflammatory Stress
hrp0098p1-66
Study of genetic variability in a cohort of familial growth retardation
hrp0098p1-67
Impact of Idiopathic Short Stature (ISS) on children’s well-being
hrp0098p1-68
Hormonal markers of ovarian function and the role in predicting reproductive lifespan in girls with Turner syndrome
hrp0098p1-69
Multisystem Endocrinology
Two Cases of Type I Sialidosis and Literature Review
hrp0098p1-70
Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
hrp0098p1-71
Serum nesfatin-1 and GLP-1 concentrations in adolescent patients with anorexia nervosa/obesity
hrp0098p1-72
A young patient with paraganglioma due to a novel SDHB gene pathogenic variant
hrp0098p1-73
10 Years’ experience in Omani cohort with variable presentation and genetically confirmed Wolfram Syndrome: Single Center Experience
hrp0098p1-74
Endocrine Complications in Childhood Primary Brain Tumor Survivors: A Single Center Study
hrp0098p1-75
The Significance of Clinical Examination in Diagnosing Genetic Diseases: An Infant with Williams-Beuren Syndrome
hrp0098p1-76
An atypical presentation of McCune Albright syndrome
hrp0098p1-77
The endocrine chameleon: expanding the phenotypic spectrum of pseudohypoparathyroidism 1A in infancy
hrp0098p1-78
Clinical Characteristics and Management Outcomes in Girls with McCune-Albright Syndrome: An Experience from a Tertiary Center
hrp0098p1-79
Pituitary, Neuroendocrinology and Puberty 1
A 12-month, Open-Label, Single-Arm, Phase 3 Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
hrp0098p1-80
Changes of lipid and glucose metabolism indices in patients with transition growth hormone deficiency after rhGH replacement therap
hrp0098p1-81
Comparative Analysis of α-Klotho Levels for the Diagnosis of Central Precocious Puberty (CPP) in Children: A Gender-Specific Study
hrp0098p1-82
Frequency and phenotypic characteristics of copy number variations in patients with Kallmann syndrome and normosmic isolated hypogonadotropic hypogonadism
hrp0098p1-83
Use of the arginine-stimulated copeptin test in paediatric polyuria-polydipsia syndrome: experience with eleven patients
hrp0098p1-84
Do aromatase inhibitors used during adolescence affect male reproductive function in adulthood? An exploratory study
hrp0098p1-85
Comprehensive study on central precocious puberty: molecular and clinical analyses in 90 patients
hrp0098p1-86
Phenotypic characteristic of a large cohort of pediatrics Argentine patients with PSIS. High Prevalence of Mutations in ROBO1 gene
hrp0098p1-87
Hypopituitarism following traumatic brain injury in children and adolescents - Long-term outcome study in a prospective patient cohort (2017-2023)
hrp0098p1-88
Sex Endocrinology and Gonads 1
Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments
hrp0098p1-89
Decreased serum DHEAS to cortisol ratio in adolescents evaluated for gender dysphoria
hrp0098p1-90
Serum steroid metabolite profiling by LC-MS/MS in two phenotypic male patients with HSD17B3 deficiency: implications for hormonal diagnosis
hrp0098p1-91
Phenotypic spectrum of
WT1
gene variants in DSD
hrp0098p1-92
EuRRECa Core Registry: results from the Gender Incongruence module
hrp0098p1-93
Comparative analysis of single cell RNA sequencing in Turner syndrome, female Graves’ disease patient, and normal female
hrp0098p1-94
Phenotypes linked to duplication upstream of
SOX9
: New insights into presentation and diagnosis
hrp0098p1-95
Study of the ovarian function and the gyneco-obstetrical profile of patients carrying a pathogenic variant of the HNF1B gene
hrp0098p1-96
Thyroid 1
Long term follow up of children with intrathyroidal ectopic thymus
hrp0098p1-97
The Influence of multiple gene mutations on the continuation of levothyroxine therapy in patients with congenital hypothyroidism due to dyshormonogenesis
hrp0098p1-98
Transient congenital hypothyroidism in a newborn with congenital goiter and compound heterozygosity for thyroglobulin
hrp0098p1-99
Evaluating Malignancy in Pediatric Thyroid Nodules: The Effectiveness of the Bethesda System and TIRADS
hrp0098p1-100
Genetic analyses in a cohort of pediatric patients with congenital hypothyroidism based on congenital hypothyroidism consensus guideline
hrp0098p1-101
Diagnosis and treatment of a child affected with a novel thyroid hormone receptor alpha (thra) gene mutation
hrp0098p1-102
The Relationship Between Antiepileptic Drug Use and Central and Peripheral Thyroid Hormone Sensitivity
hrp0098p1-103
Thyroid nodules in children and adolescents: 26 years of experience in a large single academic center
hrp0098p1-104
Presentation and outcome of ATA-Pediatric low-risk differentiated thyroid carcinoma (PLR-DTC) with high-invasive molecular alterations
hrp0098p1-105
Adrenals and HPA Axis 2
When Should We Consider Congenital Adrenal Hyperplasia in Children with Premature Pubarche: Key Features for Differential Diagnosis
hrp0098p1-106
Non-invasive biochemical monitoring for Congenital Adrenal Hyperplasia: use of urinary steroid metabolites and salivary 17α-Hydroxyprogesterone
hrp0098p1-107
Surveillance for phaeochromocytoma in children with changes in the SDHB gene may reduce morbidity: Contrasts in parent and child cases
hrp0098p1-108
Prevalence of Adrenal Insufficiency in Patients with Nephrotic Syndrome: A Prospective Observational Study
hrp0098p1-109
Does timing of Adrenocorticotropic hormone stimulation test matter?
hrp0098p1-110
Investigating Changes in Plasma Aldosterone Concentrations Following ACTH Stimulation in Healthy Individuals: A Systematic Review and Meta-Analysis on the Influence of ACTH on Aldosterone Secretion
hrp0098p1-111
Clinical characteristics and follow-up course of patients with 17α-hydroxylase/17,20-lyase deficiency in Korea: OUTSPREAD study
hrp0098p1-112
A novel genetic variant in sphingosine-1-phosphate lyase causing primary adrenal insufficiency and inborn error of immunity
hrp0098p1-113
Bone, Growth Plate and Mineral Metabolism 2
IGF1R
is most highly expressed in human iPS cell-derived proliferating chondrocytes: an approach to molecular mechanisms of IGF1 action in the human growth plate
hrp0098p1-114
Unusual Presentation of Tumor-Induced Osteomalacia with Suppressed FGF-23 in an 8-Year-Old Boy
hrp0098p1-115
Health related quality of life (HRQoL) of adolescents with XLH treated with burosumab at the end of skeletal growth (EoSG
hrp0098p1-116
GH and Vosoritide combination: report of clinical experience in two girls with achondroplasia and GH deficiency
hrp0098p1-117
Patient-Centred Data Collection Provides Comprehensive Insights into Healthcare Resource Use in Achondroplasia: Data From the Pilot Phase of the VIrtual STudy in Achondroplasia (VISTA)
hrp0098p1-118
Craniometaphyseal Dysplasia Mimicking Infantile Osteopetrosis: A Case of Skeletal Hyperostosis and Calcipenic Rickets
hrp0098p1-119
Health-related quality of life (HRQL) in paediatric patients with X-linked hypophosphatemia (XLH) in France: analysis of observational real-world registry data
hrp0098p1-120
Lower Limb deformity in different types of rickets-A systematic literature
hrp0098p1-121
Good response to bisphosphonate therapy in monozygotic twins with SCN8A mutations presenting with multiple fractures associated with seizures
hrp0098p1-122
Diabetes and Insulin 3
Severe Diazoxide-Unresponsive Congenital Hyperinsulinism Evolving to Diabetes in Early Adolescence Caused by a Homozygous p.(Cys26Tyr) ABCC8 Variant
hrp0098p1-123
Comprehensive genetic analysis of Japanese patients with congenital hyperinsulinism
hrp0098p1-124
Rising trend of type 2 diabetes following covid-19 pandemic in paediatric age group
hrp0098p1-125
Non-invasive techniques to detect early signs and determinants of diabetic peripheral neuropathy in children with type 1 diabetes
hrp0098p1-126
Molecular Characterization, Clinical phenotype and Long-Term Outcomes in Neonatal Diabetes Mellitus: nearly two decades of experience in a tertiary care pediatric diabetes clinic in north India
hrp0098p1-127
Efficacy and safety of the tandem t:slim x2 with control-iq automated insulin inchildren with type 1 diabetes previously treated with multiple daily insulin injections
hrp0098p1-128
Molecular and clinical profiles of pediatric monogenic diabetes subtypes: comprehensive genetic analysis by next-generation sequencing of 138 patients
hrp0098p1-129
Evaluation of children with secondary diabetes; a single center study over a ten year-period
hrp0098p1-130
Early Evaluation of 24-Hour Ambulatory Blood Pressure and Arterial Stiffness in Children with Type 1 Diabetes Mellitus for Protection of Vascular Health
hrp0098p1-131
Fat, Metabolism and Obesity 2
The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7
hrp0098p1-132
The effect of a lifestyle intervention program of diet, sleep and exercise on apelin-12, vaspin and resistin concentrations in children and adolescents with overweight and obesity
hrp0098p1-133
The prevention of childhood obesity is a priority: preliminary results of the "EpPOI: Education to Prevent Childhood Obesity" project
hrp0098p1-134
Genotype-phenotype correlation in Prader-Willi syndrome: A large-sample analysis in China
hrp0098p1-135
PODiaCar-Fight against Pediatric Obesity: from a predictive tool for type 2 Diabetes and Cardiovascular diseases risk to healthy educational programs
hrp0098p1-136
Evaluation of VEGF, MMP-9 and visfatin levels in adolescent girls with polycystic ovary syndrome and abdominal obesity
hrp0098p1-137
Enhanced Metabolic Profiles Following Exercise Training in Children
hrp0098p1-138
The effect of pharmacotherapy compared to lifestyle intervention on body composition in children and young people managed within a multidisciplinary weight management service
hrp0098p1-139
Neither, Either or Both Parents with Metabolic Syndrome: Comparative Study of Its Impact on Sons and Daughters
hrp0098p1-140
Assessment of Central Obesity and Body Mass Index in Youth Using a Non-Contact Radar Sensor
hrp0098p1-141
Fat, Metabolism and Obesity 3
The effect of a personalized, lifestyle intervention program on SFRP5 concentrations in children and adolescents with obesity
hrp0098p1-142
Increased early cardiovascular risk in childhood brain tumor survivors
hrp0098p1-143
Age different in anti-obesity treatment targeting BAT with Ang1-7
hrp0098p1-144
Food deserts and deprivation: Experience from a Complications of Excess Weight Service in UK
hrp0098p1-145
Evaluation of microvascular abnormalities and metabolic status in children with non-syndromic early-onset severe obesity using nailfold capillaroscopy
hrp0098p1-146
Evaluation of Test Results According to Body Mass Index of Patients Who Had a GnRH Stimulation Test with a Preliminary Diagnosis of Precocious Puberty
hrp0098p1-147
A novel homozygous frameshift mutation in ADCY3 in a consanguineous family with severe early-onset obesity
hrp0098p1-148
Obstructive sleep apnea impairs insulin clearance and hepatic insulin sensitivity in children and adolescents with obesity
hrp0098p1-149
Heterozygous Familial Hypobetalipoproteinemia: description of phenotype in affected children and adolescents in the Era of Obesityd
hrp0098p1-150
An old disease: New problem. Why should pediatric endocrinologists recognize Wernicke's Encephalopathy due to thiamine deficiency?
hrp0098p1-151
GH and IGFs 2
Etiology of severe primary isolated growth hormone deficiency: a next-generation sequencing analysis of a single center cohort
hrp0098p1-152
Enhancing growth hormone treatment adherence in Argentina: A patient support programme approach
hrp0098p1-153
Growth chart with cut-offs for poor growth response to growth hormone therapy using worldwide data in patients with growth hormone deficiency and small for gestational age
hrp0098p1-154
World-wide use of the Growzen™ Buddy smartphone app to improve adherence in patients receiving recombinant human growth hormone therapy
hrp0098p1-155
Real-world adherence to growth hormone treatment and catch-up growth in children with growth disorders from the French SCOPE study
hrp0098p1-156
The Long-Term Follow-up of Growth Hormone Treatment in a Case with 2q37 Deletion, 14q32 Duplication and Alopecia Totalis
hrp0098p1-157
Tailoring the long-acting GH therapy in the real life
hrp0098p1-158
Influence of GH and/OR IGF-1 concentrations on selected bone turnover markers in children with different short stature etiology
hrp0098p1-159
Systematic Approach To Define Clinically Significant Variants of Unknown Significance (VUS) in Children With Short Stature
hrp0098p1-160
Obesity/overweight – an unjustified obstacle to growth hormone treatment
hrp0098p1-161
An attempt to establish cut-off points for GH concentration during the inhibition test based on the analysis of the test results performed in children without gigantism
hrp0098p1-162
Growth and Syndromes 2
Real-world utility of diagnostic gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in the UK
hrp0098p1-163
Prevalence of failure to thrive in infants with Prader-Willi syndrome and the long-term effects of GH-treatment
hrp0098p1-164
A deep learning recognition model based on hand bone features for screening Turner syndrome
hrp0098p1-165
Growth hormone therapy in patient with overlap syndrome: growth outcome after one year of treatment
hrp0098p1-166
Familial Noonan Syndrome due to mutations in PTPN11 and PLOD1 genes
hrp0098p1-167
Pubertal induction amongst girls with Turner Syndrome: oral vs patch oestrogen over the last 16 years
hrp0098p1-168
Compliance in children with growth hormone deficiency treated with recombinant growth hormone (rhGH): a multicentre study in Poland
hrp0098p1-169
Growth hormone therapy is not efficient in improving the adult height of children with Hypochondroplasia
hrp0098p1-170
Referrals for short stature to a regional pediatric endocrinology referral: Similarities, trends, and variations in 780 children over 10 years
hrp0098p1-171
Impact of Feeding Types on Catch-Up Growth in Early Infancy Among Small-for-Gestational-Age Infants: A Nationwide Korean Study
hrp0098p1-172
Pituitary, Neuroendocrinology and Puberty 2
Incidence of delayed puberty: A nationwide register-based study
hrp0098p1-173
International Practice in Management of Puberty for Patients with Hypogonadotropic Hypogonadism
hrp0098p1-174
Current Practice of Managing Hypogonadotropic Hypogonadism in Male Infants during Minipuberty – an International Survey
hrp0098p1-175
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche
hrp0098p1-176
Androgen Receptor Cag Repeat Polymorphism Might Be A Possible Cause of Familial Constitutional Delay in Growth and Puberty
hrp0098p1-177
Investigation of the Emotional and Psychosocial Dimensions of Girls Diagnosed with Idiopathic Central Precocious Puberty
hrp0098p1-178
A 31-year referral center experience in pediatric growth hormone secreting pituitary adenomas
hrp0098p1-179
Retrospective Analysis of Pediatric Craniopharyngioma at a National Referral Center: A 37-Year Experience. Clinical Characteristics and Treatment Outcomes
hrp0098p1-180
Characterization of puberty-regulating microRNAs within the hypothalamus of female mice
hrp0098p1-181
Pituitary, Neuroendocrinology and Puberty 3
A description of a national meeting for hypothalamo-pituitary-axis-tumours
hrp0098p1-182
Arginine-stimulated copeptin for Central Diabetes Insipidus diagnosis in children
hrp0098p1-183
Assessment of hypogonadotropic hypogonadism using a gonadotropic-gonadal stimulation test with subcutaneous Triptorelin: preliminary results
hrp0098p1-184
Genetic analysis of a European cohort of ROHHAD patients
hrp0098p1-185
Utility of First-Morning-Voided Urinary Total LH in Detecting the Onset of Central Puberty
hrp0098p1-186
Moderate day-to-day variation in first morning urine total luteinizing hormone levels supports the use of a single determination to identify imminent puberty
hrp0098p1-187
Childhood-onset craniopharyngioma: 26 years of experience at Children's Memorial Health Institute (CMHI)
hrp0098p1-188
COVID-19 stressful conditions in the increase of central precocious puberty: long-term follow-up and timelines of this phenomenon demonstrate the declines to pre-pandemic levels after the end of online classes period in Italy
hrp0098p1-189
The first description of an MC4R variant in a patient with Kallmann syndrome and obesity
hrp0098p1-190
Sex Endocrinology and Gonads 2
Assessing quality of care for people with differences of sex development (DSD) – results of an annual benchmarking of DSD centres in Germany
hrp0098p1-191
Sex Steroid Metabolite Profile and Gonadotrophins during Hormone Therapy in Transgender Adolescents
hrp0098p1-192
Under the Lens: A Study of Childhood Gender Identity Through the Toy Preference Test and its relation to minipuberty
hrp0098p1-193
Consequences for treatment following the German Act on the Protection of Children with Differences in Sexual Development (DSD)
hrp0098p1-194
Clitoromegaly - Size does matter
hrp0098p1-195
Survey of pediatricians on the care provided to children with gender diversity
hrp0098p1-196
46 XY Gonadal Dysgenesis- Transmission of a Maternal Mosaic Novel
DMRT1
Mutation
hrp0098p1-197
Course and Predictors of Puberty in Boys with Isolated Micropenis
hrp0098p1-198
Thyroid 2
Novel compound heterozygous mutations in the SBP2 gene
hrp0098p1-199
Severe congenital hypothyroidism due to a novel homozygous variant affecting the conserved CAGYC region of TSHβ
hrp0098p1-200
Potential Role of Selected miRNAs in the Pathogenesis of Autoimmune Thyroid Diseases in Children and Adolescents
hrp0098p1-201
Association between long-term exposure to fine particulate matter and onset of autoimmune thyroid diseases in children and adolescents: Evidence from a nationwide cohort study in Korea
hrp0098p1-202
Experience with Combined T4 and T3 Therapy in Childhood Hypothyroidism
hrp0098p1-203
Impact of the Presence of a Feeding Tube on Tiratricol Maintenance Dosing and Efficacy Outcomes in Patients with MCT8 Deficiency
hrp0098p1-204
Treatment Outcomes in Pediatric Differentiated Thyroid Carcinoma: A Single Center Experience
hrp0098p1-205
Usefulness of T4 measurement in neonatal screening for congenital hypothyroidism - Experience of two Italian Centers
hrp0098p1-206
Newborn screening for congenital hypothyroidism and re-screening at two weeks of life in infants born to mothers with thyroid diseases
hrp0098p1-207
Adrenals and HPA Axis 3
The prevalence of nephrocalcinosis among patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency – one-centre experience. Do we need a regular screening?
hrp0098p1-208
Early Childhood-Onset Non-Classical CAH (NCCAH) Presenting with Premature Pubarche and Clitoromegaly Caused by CYP21A2 Duplication Without Gene Mutation in Triplets
hrp0098p1-209
Triple A syndrome: A common cause of primary adrenal insufficiency in Algeria
hrp0098p1-210
Non tumoral ACTH-Independent Cushing Syndrome in Pediatric Patients: A Retrospective Observational Cohort Study
hrp0098p1-211
Negative Impact of Supraphysiological Glucocorticoid Dosing on Growth and Changes in Glucocorticoid Dose and Androstenedione Health States in Patients with Classic Congenital Adrenal Hyperplasia: Results from the CAHtalog™ Patient Registry
hrp0098p1-212
Prematurity and low birth weight may be key indicators for a low peak cortisol on neonatal Short Synacthen Tests
hrp0098p1-213
The unique urinary steroid metabolome in infants with P450 oxidoreductase deficiency in the first week of life
hrp0098p1-214
Who should be screened for electrolyte imbalances in the outpatient endocrinology clinic?
hrp0098p1-215
Bone, Growth Plate and Mineral Metabolism 3
Characterization of a large cohort of 99 argentinian patients with hereditary hypophosphatemic rickets (HHR) followed in a single pediatric tertiary center
hrp0098p1-216
Preterm born young men have lower age and gender specific lumbar spine Z-scores compared to preterm born young women
hrp0098p1-217
Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor Mutation: Experience with Cinacalcet and Parathyroidectomy
hrp0098p1-218
Prospective longitudinal assessment of bone mineral density, circulating markers of bone turnover and changes in body composition in children and adolescents treated for acute lymphoblastic leukemia
hrp0098p1-219
Safety and efficacy of continuous subcutaneous PTH (1-34) infusion therapy (CSPI) for severe autosomal dominant hypocalcaemia type 1 (ADH1) in Children and Young People (CYP)
hrp0098p1-220
A 10-year non-interventional registry of patients with FGF23-related hypophosphatemic rickets and osteomalacia in Gulf Cooperation Council (GCC)
hrp0098p1-221
Expanding the clinical phenotype of PKDCC Rhizomelic Skeletal Dysplasia – A Case Report and literature review
hrp0098p1-222
Determinants of bone mineral density in healthy term-born children at age 6 months
hrp0098p1-223
Rare diseases, rarely diagnosed: Mapping the accuracy of laboratory screening for rare bone disorders in Austria
hrp0098p1-224
Lower Limb deformity in different types of rickets - A systematic literature review
hrp0098p1-225
Diabetes and Insulin 4
Microvascular complications of T1DM in children and adolescents at tertiary care hospital, pakistan
hrp0098p1-226
Higher levels of c-peptide at the onset of Type 1 Diabetes are correlated with better glycemic control after 2 years from the diagnosis in a cohort of pediatric patients
hrp0098p1-227
The use of pumps with Automated Insulin Delivery (HCL/AHCL) improves the Sleep Quality of Children and Adolescents with Type 1 Diabetes and of their parents/caregivers
hrp0098p1-228
Nighttime Blood Pressure Disturbances in Children with Long-Term Type 1 Diabetes
hrp0098p1-229
Screening for Dysglycaemia in Children Amidst a Global Obesity Crisis
hrp0098p1-230
Children and Young People and Parent and Carer Perspectives on Provision of Type 2 Diabetes Mellitus Care in England and Wales – Insights from the PREM survey report (2021/22)
hrp0098p1-231
Dietary interventions for the management of type 2 diabetes mellitus in childhood and adolescence: a systematic review
hrp0098p1-232
Early Markers of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes
hrp0098p1-233
Fat, Metabolism and Obesity 4
Diploid/triploid mosaicism: a rare cause of metabolic syndrome and diabetes in children
hrp0098p1-234
Towards a “Genetic Obesity Risk Score”: preliminary data from a single-centre cohort of obese children and adolescents
hrp0098p1-235
Prevalence of variants in the Leptin Melanocortin 4 receptor (MC4R) pathway in an Israeli cohort of children with severe obesity and their clinical and laboratory characteristics
hrp0098p1-236
Health transition of children with obesity - a comprehensive approach from a German obesity center: a prospective cohort analysis
hrp0098p1-237
Predictive Value of Impulse Oscillometry and Hepatic Fat Content for Obstructive Sleep Apnea Syndrome in Obese Children and Adolescents
hrp0098p1-238
Evolution of the cytokine profile following duodenal-jejunal bypass liner in adolescents with obesity
hrp0098p1-239
Patient and parent experience of a group exercise programme collaboration with a tertiary paediatric weight management service
hrp0098p1-240
Genetics of obesity: results from a tertiary paediatric weight management service
hrp0098p1-241
GNAS
mutation: an under-rated cause of severe early-onset obesity!
hrp0098p1-242
Fetal and Multisystem Endocrinology
Experience with Cinacalcet in Neonatal Severe Hyperparathyroidism Due to
CASR
Mutation
hrp0098p1-243
Tear proteomics in children and adolescents with congenital hyperinsulinism
hrp0098p1-244
The LIFE-MILCH study: first data on the exposure to Endocrine Disrupting Chemicals (EDCs) in urine and breast milk (BM) from end of pregnancy to 12 months of life
hrp0098p1-245
Rarity of congenital adrenal hyperplasia in children born verypreterm: Possible mechanism and implication for newborn screening
hrp0098p1-246
Congenital hyperinsulinism (mutation in GCK gene) and congenital hypothyroidism in one of the monozygotic twins
hrp0098p1-247
Assessment of carbohydrate and lipid metabolism in patient with glycogen storage disease type 0a and celiac disease at diagnosis and after 3 years of follow-up - case report
hrp0098p1-248
The prevalence of thyroid disorders and coeliac disease in children wih type 1 diabetes mellitus seen in a tertiary hospital in resource limited setting
hrp0098p1-249
In an era of advanced genomic testing- is karyotype still relevant?
hrp0098p1-250
The Use Of EQ5D For Assessment Of Health Related Quality Of Life And Its Determinants In Children With Complex Endocrine Conditions
hrp0098p1-251
Growth and Syndromes 3
Growth Hormone Therapy in Prader Willi Syndrome – Audit of Age of Initiation Over Time in a Tertiary Centre
hrp0098p1-252
Establishing a Nurse-led Transition Clinic for Young People with Congenital Adrenal Hyperplasia (CAH): Quality Improvement Project
hrp0098p1-253
Growth Response to Medical Intervention in an Observational Real-life Study of Children with Growth Delay: A Causal Inference Method
hrp0098p1-254
Health and life risks in children with achondroplasia – multicenter study
hrp0098p1-255
Height outcomes in children born small for gestational age (SGA) from combined CrescNet and REPAR cohorts: The impact of either spontaneous or growth hormone-induced catch-up growth
hrp0098p1-256
Molecular and phenotypic characteristics of chinese neurofibromatosis type 1 children
hrp0098p1-257
First Real-Life Data on the Use of Long-Acting Growth Hormone Somatrogon in Türkiye
hrp0098p1-258
Polysomnography Findings and Respiratory Problems in Prader-Willi Syndrome: The Effect of Growth Hormone Treatment
hrp0098p1-259
Long-Acting Growth Hormone Therapy in Children with Growth Hormone deficiency – A two centre real world experience from UK
hrp0098p1-260
Recombinant Growth Hormone Therapy in Pediatric Renal Failure: 30-Year-Experience in a Tertiary Hospital
hrp0098p1-261
Growth and Syndromes 4
A novel comprehensive bioinformatic strategy could significantly enhance the molecular genetic diagnosis in growth restriction phenotypes
hrp0098p1-262
Reduced final height in boys after allogeneic hematopoietic stem cell transplantation (HSCT) for childhood cancer: does pubertal growth spurt matters?
hrp0098p1-263
Single center prospective study on the Efficacy and Safety of Vosoritide Therapy in Achondroplasia: A Comprehensive Evaluation at Three and Six Months
hrp0098p1-264
Use of Vosoritide in Children with Achondroplasia - Real Life Experince
hrp0098p1-265
AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies
hrp0098p1-266
The clinical burden and healthcare resource utilization among children and adolescents with achondroplasia: an observational cohort study using Optum’s de-identified Clinformatics
®
Data Mart Database
hrp0098p1-267
Mechanisms of Growth Failure in a Mouse Model of Aggrecan Deficiency: Insights into Chondrocyte Function and Akt Signaling
hrp0098p1-268
Effect of treatment with Isotretinoin on early bone maturation: A Case Report
hrp0098p1-269
Expression levels of serum AMH and INHB in children with different karyotypes of Turner syndrome and assessment of their ovarian reserve function
hrp0098p1-270
Pituitary, Neuroendocrinology and Puberty 4
The Use Of GloBE-Reg As A Global Platform For Performing Safety & Efficacy Studies Of rhGH Therapy
hrp0098p1-271
Nonfunctioning pituitary adenomas in childhood: A single-center experience
hrp0098p1-272
Prospective assessment of hypothalamic dysfunction (HD) in congenital or tumorous diseases and impact on quality of life
hrp0098p1-273
Somatotropinomas in Pediatric Endocrinology Practice: Single Center Experience
hrp0098p1-274
Endocrine Deficiency after Photon and Proton Radiotherapy for Medulloblastoma in Hokkaido University Hospital, Japan
hrp0098p1-275
Associations Among Clinical, Hormonal, and Imaging Data with Developmental Outcomes in Congenital Combined Pituitary Hormone Deficiency: A National Multicenter Retrospective Study
hrp0098p1-276
A rare cause of hypogonadotropic hypogonadism:
KLB
gene variant in a prepubertal boy evaluated for micropenis
hrp0098p1-277
Water deprivation test in children: challenging but still necessary to diagnose central diabetes insipidus
hrp0098p1-278
Value of serum AMH and INHB in the diagnosis and treatment of central precocious puberty and early and fast puberty girls
hrp0098p1-279
Sex Endocrinology and Gonads 3
Validation Of A New Short Parent Reported Outcomes (PRO) Questionnaire For Boys With A Condition Affecting Sex Development (CSD)
hrp0098p1-280
Comparison between, clinical, metabolic and hormonal parameters and selected microRNAs in adolescent girls with PCOS and healthy controls
hrp0098p1-281
Estrogen and progesterone in immune dysfunction at childhood follow up of preterm infants
hrp0098p1-282
Care in the first weeks after a suspected DSD diagnosis – results of the Empower-DSD information management program
hrp0098p1-283
Face processing patterns in individuals with gender incongruence or differences of sex development: an eye-tracking study
hrp0098p1-284
A Little Known But Very Common Phenotype in Patients with Congenital Neutropenia Due to HAX1 Deficiency: Premature Ovarian Failure
hrp0098p1-285
Thyroid 3
Has COVID-19 Changed Pediatric Graves' Disease? A Study Investigating Post-Pandemic Trends
hrp0098p1-286
Abstract unavailable
hrp0098p1-287
Assessment of regulatory B cells in peripheral blood and zinc transporter 8 expression in thyroid tissue in children with autoimmune thyroid diseases
hrp0098p1-288
Papillary thyroid cancer in a teenager with thyroid hormone resistance syndrome: features of postoperative management
hrp0098p1-289
A Retrospective Observational Study of Patients with Differentiated Thyroid Cancer from a Pediatric Endocrinology Clinic in Crete
hrp0098p1-290
Response to TRIAC therapy in a child with Resistance to Thyroid Hormone beta and behavioural abnormalities
hrp0098p1-291
Congenital autoimmune thyreoiditis with hypothyroidism: first expression of a STAT-3-associated multisystemic disease with further severe autoimmune manifestations
hrp0098p1-292
Genetic Etiology in Congenital Hypothyroidism
hrp0098p1-293
Late Breaking 1
Prolacrin associates to adrenal androgens during adrenarche
hrp0098p1-294
GC-MS urinary steroid metabolome reveals substantial dysregulation of adrenal, gonadal, and neuroactive steroids in adolescents with depressive symptoms
hrp0098p1-295
Evaluating Setmelanotide Treatment for 12 Months in Pediatric Age Groups With Rare Melanocortin-4 Receptor Pathway–Related Obesity: Efficacy in Weight Reduction and Safety Outcomes
hrp0098p1-296
Three-year results on weight and eating disorders with digi-physical treatment in paediatric obesity: A pragmatic clinical trial
hrp0098p1-297
The severity and correlates of depressive symptoms in adolescents with obesity compared to normal adolescents in Hong Kong using a validated Patient Health Questionnaire-9 screening tools
hrp0098p1-298
A Real-World Pharmacovigilance Assessment and Literature Review of Lymphoma Development in Lipodystrophy and Congenital Leptin Deficiency
hrp0098p1-299
The Diagnostic and Therapeutic Monitoring Value of Morning Urinary Gonadotropins for Central Precocious Puberty in Girls with Different BMI
hrp0098p1-300
The incidence of central precocious puberty and the effect of BMI (real-world data In Korea)
hrp0098p1-301
Evaluation of Copeptin Level in Children and Adolescents Monitored with Central Diabetes Incipidus
hrp0098p1-302
Treating Arginine Vasopressin Deficiency in Infants is a Challenging Condition: A 20-year Single-Center Study
hrp0098p1-303
Late Breaking 2
ER stress relief drives ß-cell proliferation
hrp0098p1-304
Lipodystrophy severity score improves in patients with generalized lipodystrophy following metreleptin treatment
hrp0098p1-305
Role of Cubulin gene variants in the development of microalbuminuria in children with type1 diabetes
hrp0098p1-306
The man in the LOOP: Ramadan fast in Type 1 diabetic patients with a Closed Loop automated insulin delivery system
hrp0098p1-307
Empowering diabetes self-management and peer connections – The role of a community young adult diabetes specialist nurse (CODSN) and diabetes youth worker (YW) in improving outcomes, Transition Safe and Sound (TraSS), an NHS England pilot
hrp0098p1-308
Safety and efficacy of efpegerglucagon in patients with congenital hyperinsulinism: interim results from a phase 2 study
hrp0098p1-309
The iPhone Measure app as a measuring device for the height in pediatrics: a reliability study
hrp0098p1-310
Heterozygous
PLAG1
gene variants causing Silver-Russell syndrome in a case series of 4 patients
hrp0098p1-311
SGPL1 deficiency is associated with reduced lipid droplet formation and impaired steroidogenesis in Leydig cells
hrp0098p1-312
Do We Need Seasonal Thyroid Hormone Reference Values in Pediatric Endocrinology? Results from a Population-Based Study
hrp0098p1-313
Poster Category 2
Adrenals and HPA Axis
Compromised linear growth and Final adult height in children with classic CAH 21OHD
hrp0098p2-1
ESPE School: Sharing Knowledge to Save Lives - Developing and Standardizing Education for Healthcare Providers and Families with Children with Adrenal Insufficiency in Kazakhstan
hrp0098p2-2
The Impact of the COVID-19 Pandemic on Patients with Adrenal insufficiency
hrp0098p2-3
Pitfalls in diagnosis of Congenital Adrenal Hyperplasia due to 3beta-hydroxysteroid dehydrogenase type 2 (HSD3B2) deficiency – A Problem of Assay Interference
hrp0098p2-4
Pharmacological therapy of adrenal hypercortisolism in a boy with suspected isolated micronodular adrenal hyperplasia (iMAD) due to a mutation in the PDE11A gene
hrp0098p2-5
Diagnosis of Cushing's Disease with Desmopressin-Induced Bilateral Inferior Petrosal Sinus Sampling: A Case Report
hrp0098p2-6
ESPE Caucasus&Central Asia School (C&CAS) Sharing Knowledge for Saving Patients' Lives: Organizing pediatric endocrinology care for patients with adrenal insufficiency in Armenia
hrp0098p2-7
Missed Diagnosis of Triple A Syndrome in a Syrian 3 year-old boy in Lebanon
hrp0098p2-8
The Role of Midkin and Inflammatory Cytokines in The Pathophysiology of Metabolic Syndrome in Children and Adolescents with Classical Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Enzyme Deficiency
hrp0098p2-9
Early Diagnosis of Adrenoleukodystrophy in Two Siblings
hrp0098p2-10
Iatrogenic adrenal insufficiency – a single centre response to increasing awareness and instituting management in non-endocrine specialities
hrp0098p2-11
Central adrenal assessment in a group of prepuberal Prader Willi Syndrome patients in a tertiary center
hrp0098p2-12
X-linked adrenoleukodystrophy in two male siblings; Endocrinological aspects of the disease, and therapeutic approaches
hrp0098p2-13
Clinical characteristics of rare forms of paediatric congenital adrenal hyperplasia (CAH) in a single tertiary centre
hrp0098p2-14
Premature Adrenarche, Body Composition and Metabolic Dysfunction – Characterisation of a Pilot Cohort
hrp0098p2-15
The challenge of diagnosis and management of micronodular adrenocortical disease in a 7-year old girl with cyclic cushing syndrome: a case report
hrp0098p2-16
17OHP and cortisol day curve profiles for children using hard-capsule modified release hydrocortisone as compared with immediate release hydrocortisone
hrp0098p2-17
Determination of Anti-Müllerian Hormone and Inhibin B Reference Ranges According to Pubertal Stages in Children and Adolescent Girls
hrp0098p2-18
Metabolic risk factors in children with Premature Adrenarche – a systematic review and meta-analysis
hrp0098p2-19
Clinical spectrum and outcome of adrenocortical tumours in children
hrp0098p2-20
Should we routinely screen for adrenal rests in Congenital Adrenal hyperplasia?
hrp0098p2-21
Severe Adrenocortical Carcinoma Presentation with Vena Cava Involvement in a 1-Year-Old Boy: A Case Presentation and Management Considerations
hrp0098p2-22
Adrenal Lesions Evaluated in A Pediatric Endocrinology Department
hrp0098p2-23
Genotype-Phenotype correlations in three patients with CYP21A2 picked up by 17- ɑ OHP screening
hrp0098p2-24
X-linked congenital adrenal hypoplasia due to a novel mutation in NR0B1 gene
hrp0098p2-25
Bone, Growth Plate and Mineral Metabolism
Bisphosphonate Therapy in a Pediatric Case Series with Monostotic Form of Fibrous Dysplasia: A Single-Center Retrospective Analysis of Efficacy and Safety
hrp0098p2-26
Infantile hypercalcemia with CYP24A1 variant triggered by fortified milk
hrp0098p2-27
HDR syndrome due to a new mutation in the GATA3 gene
hrp0098p2-28
Vitamin D dependent rickets Type 2A: A case series of two siblings with novel mutation in vitamin D receptors responded to high dose oral calcium and calcitriol
hrp0098p2-29
Investigation of GNAS Gene Mutation and Clinical Correlations in Patients Followed with the Diagnosis of Pseudohypoparathyroidism
hrp0098p2-30
Bisphosphonates: A promising treatment for osteolytic lesion in Langerhans cell histiocytosis
hrp0098p2-31
A rare presentation of parathyroid adenoma as bilateral genu valgum in an adolescent Pakistani girl
hrp0098p2-32
Dysplasia Epiphysealis Hemimelica combined with Familial Hypocalciuric Hypercalcemia – can the calcium-sensing receptor have a role in expansive bone lesions?
hrp0098p2-33
Persistent Hypocalcemia In a Pakistani Infant: A Rare Activating
CaSR
Mutation
hrp0098p2-34
Tibial-tubercle avulsion and patellar-tendon rupture in an adolescent with osteogenesis imperfecta
hrp0098p2-35
KIF22 Mutation with Spondyloepimetaphyseal Dysplasia with Joint Laxity, Leptodactylic Type 2 (SEMDJL2)
hrp0098p2-36
Vosoritide Therapy in Children with Achondroplasia: Single-Center Experience
hrp0098p2-37
Kenny-caffey syndrome in the neonatal period
hrp0098p2-38
PTHLH gene mutation: A rare diagnosis of skeletal dysplasia
hrp0098p2-39
An adolescent health care clinic at King Abdulaziz Medical City, Jeddah, Saudi Arabia
hrp0098p2-40
Linear growth in children and adolescents treated with zoledronic acid (ZA): A Single Institution Case Series
hrp0098p2-41
The etiological distribution of elevated serum alkaline phosphatase levels and characteristics of children with transient hyperphosphatasemia
hrp0098p2-42
The development of low selenium concentrations in children undergoing liver transplantation
hrp0098p2-43
Use of denosumab in aneurysmal bone cyst and giant cell tumor in a third-level pediatric center
hrp0098p2-44
Hereditary hypophosphatemic rickets with hypercalciuria: a rare disorder not to be forgotten about
hrp0098p2-45
Advanced bone age in short stature due to ACAN gene mutation: a case report
hrp0098p2-46
Evaluation of Pediatric Cases with ACAN Gene Variants
hrp0098p2-47
Two likely compound heterozygous variants in
SLC34A1
causing idiopathic infantile hypercalcemia (IIH) type 2 - a case report
hrp0098p2-48
A case of parathyroid carcinoma in a pediatric patient
hrp0098p2-49
Lysinuric Protein Intolerance: A Case Report of a Child Presenting with Multiple Fractures to Bone Clinic
hrp0098p2-50
Real-world experience with vosoritide treatment in achondroplasia: A single-center report from Turkey
hrp0098p2-51
Current challenges in diagnosis, treatment, and follow-up of children with parathyroid hormone dysfunction – lessons learned from a cohort of children presenting with hypocalcaemia
hrp0098p2-52
Bone mineralization at around age 5 years in children born very preterm compared to children born term
hrp0098p2-53
The clinical burden and healthcare resource utilization among children and adolescents with osteogenesis imperfecta: an observational study using Optum’s de-identified Clinformatics
®
Data Mart Database
hrp0098p2-54
Bone Mineral Density in Children with Inflammatory Bowel Disease
hrp0098p2-55
Real-world effectiveness of vosoritide in children with achondroplasia: Results from 18 months follow-up in France
hrp0098p2-56
Diabetes and Insulin
Sleep disturbances in children and adolescents with type 1 diabetes mellitus: Prevalence, and relationship with diabetes management
hrp0098p2-57
The Relationship of Serum Diabetes Antibodies with the Development of Early Diabetic Retinopathy Findings in Children with Type 1 Diabetes Mellitus
hrp0098p2-58
Impact of Telemonitoring on Glycemic Control in Pediatric Patients with Type 1 Diabetes Mellitus
hrp0098p2-59
The incidence of type 1 diabetes among estonian children in 2007-2022 in comparison with the data from 1983 to 2006 and the impact of the covid-19 pandemic
hrp0098p2-60
A Novel Disease-causing Variant of INS-MODY with a Unique Phenotype
hrp0098p2-61
Founder WSF1 Mutation Causing Wolfram Syndrome in the Druze Population in Israel
hrp0098p2-62
The frequency of anemia and the evaluation of related factors in patients with type 1 diabetes mellitus
hrp0098p2-63
Hybrid closed loop systems: are they all the same? 1-year of follow-up outcomes of two hcls in children with type 1 diabetes: a real-life based study
hrp0098p2-64
Diabetes mellitus, macrocytosis and skin pigmentation disorder in a child with large-scale mtdna deletion
hrp0098p2-65
Genetic analysis and treatment of congenital hyperinsulinemic hypoglycemia: A single center's experience
hrp0098p2-66
Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy In Children <7 years with Type 1 Diabetes
hrp0098p2-67
Evaluation of the relationship between glucose levels and oxidative stress through ischemia-modified albumin levels during oral glucose tolerance test
hrp0098p2-68
Venous Sodium, Potassium, and Glucose Results on Rapid Arterial Blood Gas Analyzer in Children with Diabetic Ketoacidosis: Are the Values Comparable with Results Obtained from the Central Laboratory?
hrp0098p2-69
Efficacy of Advanced Hybrid Closed-Loop System Medtronic MiniMed™ 780G in Japanese children with type 1 diabetes mellitus (T1DM)
hrp0098p2-70
Severe Acute Kidney Injury in an Adolescent with Diabetic Ketoacidosis
hrp0098p2-71
Neonatal Diabetes, Thrombocytopenia, and Atopic Dermatitis: A Diagnostic Challenge of IPEX Syndrome
hrp0098p2-72
Neonatal Diabetes Due to Insulin Gene Mutation
hrp0098p2-73
Incidence and modes of presentation of childhood type 1 diabetes mellitus in Malta between 2012 and 2023
hrp0098p2-74
Rabson Mendenhuall Syndrome: the phenotype, genotype and management in a cohort of Sudanese children
hrp0098p2-75
Severe hypertriglyceridemia: a rare but serious complication of diabetic ketoacidosis in children
hrp0098p2-76
Congenital Generalized Lipodystrophy in Down Syndrome patient
hrp0098p2-77
Permanent Neonatal Diabetes in Kosova, incidence, genetics, clinical phenotype and treatment
hrp0098p2-78
Linking diabetes and severe cardiac malformations: a GATA6 mutation
hrp0098p2-79
Influence of SARS-COV-2 virus on initial manifestation of type 1 diabetes in children: national data from latvia
hrp0098p2-80
“Sweet” lies detector; Factitious Diabetes Mellitus as a rare presentation of Munchausen by Proxy syndrome
hrp0098p2-81
Investigating the Confidence and Training needs of the Wythenshawe Hospital Emergency Department Clinicians in the Management of Paediatric Type 1 Diabetic Emergencies
hrp0098p2-82
Phenotypic Spectrum at Diagnosis of Age-Related Endotypes of Type 1 Diabetes Mellitus: A Cross-Sectional Study in China
hrp0098p2-83
Endocrine Evaluation in Patients with Cystic Fibrosis: A Retrospective Study from Single Tertiary Center
hrp0098p2-84
Clinical Characteristics and follow-up of Type 2 Diabetes in Children and Adolescents: A Single Center Experience
hrp0098p2-85
Endotypes in diabetes, different diabetes, different management?
hrp0098p2-86
Interim analysis of the prospective evaluation of putatively influential factors associated with the timing and duration of honeymoon phase in newly diagnosed pediatric patients with Type 1 Diabetes
hrp0098p2-87
Effectiveness of Different Insulin Delivery Systems Among Preschool Children with Type 1 Diabetes
hrp0098p2-88
Testing a new “accelerator hypothesis” covid-19 pandemic-related in new onset pediatric type 1 diabetes: a retrospective analysis 2010-2022
hrp0098p2-89
Type 1 diabetes incidence in children aged under 15 years living in Ireland during 2022
hrp0098p2-90
Prevalence, clinical, immunological and biochemical characteristics of children with Familial T1D in Kuwait
hrp0098p2-91
Fat, Metabolism and Obesity
Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?
hrp0098p2-92
Prevalence of metabolic syndrome components and atherogenic index in obese nondiabeticchildren: anthropometric comparison with parents
hrp0098p2-93
Phenotype, Genotype and Follow-up of Pediatric Hypertriglyceridemia: An Indian Perspective
hrp0098p2-94
The Effect of Vitamin D Supplementation on Fatty Liver Disease and Insulin Resistance
hrp0098p2-95
Correlation between glucose metabolism disorder and bone turnover markers in obese adolescents
hrp0098p2-96
Improvement of Cardiometabolic Risk Factors and Psychosocial Health in Children and Adolescents with Excess Adiposity following Implementation of a Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program
hrp0098p2-97
The role of Glucagon-Like Peptide 1 Receptor Agonists for Weight Control in Individuals with Acquired Hypothalamic Obesity- A Systematic Review
hrp0098p2-98
Body Composition in Pediatric Patients with Craniopharyngioma following Surgical Treatment
hrp0098p2-99
Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset
hrp0098p2-100
Weight development and neuroendocrine deficits following proton beam therapy in children with craniopharyngioma
hrp0098p2-101
Diagnosis of monogenic obesity: the uncertainty due to the occurrence of VUS has decreased over time. A single center experience of variant follow-up
hrp0098p2-102
Different impact of BMI on bones mineralisation between obese and lean boys: Cross-Sectional Study
hrp0098p2-103
Silent Dangers: How Insulin Resistance and Trimethylamine N-Oxide Fuel Early Atherosclerosis in Obese Children. A preliminary study
hrp0098p2-104
Successful Semaglutide Treatment in Two Sisters with Congenital Leptin Deficiency and Hyperphagia
hrp0098p2-105
Comparative Analysis of the Discriminative Ability of BMI, TMI, and BMI zscore in Establishing Metabolic Syndrome Risk
hrp0098p2-106
Xq27.3-q28 Duplication Containing FMR1 Gene: Case Presentation and Literature Review of Familial X-linked Hypogonadism, Gynecomastia, Short Stature, Intellectual Disability and Obesity Syndrome
hrp0098p2-107
Prevalence and risk factors of Metabolic Associated Fatty Liver Disease (MAFLD) in polish children and adolescents with severe obesity
hrp0098p2-108
Single-center experience in using a once weekly Semaglutide injection in adolescents with obesity +/- Type 2 diabetes
hrp0098p2-109
Identification of menstrual disorders in Polish adolescent girls with severe obesity. Preliminary results of the Polish-German research project on early-onset severe obesity
hrp0098p2-110
The level of vascular endothelial adhesion factor (VEGF) correlate with hyperlipidemia in obese children and type 1 diabetes in important as the marker of cardiovascular disease
hrp0098p2-111
Risk Factors for Obesity in Children with Hypothalamic Masses
hrp0098p2-112
Impact of Semaglutide on body composition, cardiometabolic variables, glycaemic status, and quality of life in adolescents with severe obesity
hrp0098p2-113
The Association between Metabolic markers, Liver function enzymes, Vitamin D level, and Lung Function Tests in Overweight/obese Children with and without Asthma
hrp0098p2-114
Changes in Weight Distribution & Trends in Obesity Prevalence among Children and Adolescents in East Asia: Insights from NCD-RisC Data
hrp0098p2-115
Prevalence of Central Obesity Among Adolescent School Children in Rural Kerala, South India
hrp0098p2-116
A paediatric case of Progeroid Lipodystrophy: diagnosis, follow-up and new insights from a de novo mutation in the POLD1 gene
hrp0098p2-117
Semaglutide treatment for severe obesity after craniopharyngioma surgery with or without radiotherapy
hrp0098p2-118
Use of medical technology and daily weight measurements in the management of severe childhood obesity
hrp0098p2-119
Whole Genome Sequencing reveals a novel leptin splice region variant in two siblings with morbid childhood obesity
hrp0098p2-120
Anthropometric, Laboratory and Clinical Evaluation of Patients with Syndromic Obesity Regarding to Their Genetic Diagnoses
hrp0098p2-121
The role of obesity on lung function in children and adolescents with asthma
hrp0098p2-122
Evaluation of metabolic syndrome risk using metabolic syndrome z-score in Bardet-Biedl Syndrome patients with various genotypes
hrp0098p2-123
Genetic Causes of Obesity in children from a tertiary hospital in UAE
hrp0098p2-124
The Metabolic Effect of Liraglutide as Add on Treatment to Lifestyle Modification on Obese Adolescents in a Tertiary Centre, Riyadh
hrp0098p2-125
First year outcomes in a Paediatric Complications of Excess Weight (CEW) Service
hrp0098p2-126
MC4R
variant in a four-generation family with early-onset severe obesity
hrp0098p2-127
Identification and Functional Validation of Rare Missense Variants in
PLXNA1
as a Candidate Gene for Severe Early-onset Obesity
hrp0098p2-128
Evaluation of genetic etiology and genotype-phenotype association in endogenous obesity
hrp0098p2-129
Genetic etiology and clinical phenotype of childhood obesity based on whole exon sequencing technology
hrp0098p2-130
Fetal, Neonatal Endocrinology and Metabolism
The Impact of Congenital Hyperinsulinism on Family Finances and Time: A Report from the HI Global Registry
hrp0098p2-131
A rare metabolic disease mimicking starvation hypoglycemia: fructose 1-6 bisphosphatase deficiency
hrp0098p2-132
Experiences of infant feeding in congenital hyperinsulinism: a thematic analysis
hrp0098p2-133
Long-term follow-up of children and adolescents with congenital hyperinsulinism: a 16 years’ single center experience
hrp0098p2-134
Octreotide efficacy and Safety in Children withhyperinsulinism: evidence from two Chinesecenters
hrp0098p2-135
Hypoglycemia workup in pediatric emergency room before and after an implementation of an improved management protocol
hrp0098p2-136
GH and IGFs
Isolated Speech and Mild Global Developmental Delay with Abnormal Genetic Microarray and IGF1 Resistance in a 6-Year-Old Female
hrp0098p2-137
Comparative Growth Trajectories of SGA and AGA Preterm Infants Over the First Five Years
hrp0098p2-138
Postnatal Growth Patterns of Small for Gestational Age Infants Under 1.5 kg Over a Five-Year Period
hrp0098p2-139
Postnatal Growth Trajectories for 5 years for AGA Preterm Infants Born <1.5 kg
hrp0098p2-140
Insight into IGF1 Receptor Gene Mutations: Implications for Growth Disorders and Treatment - A Comprehensive Review
hrp0098p2-141
Comparative Study of Glucose Response to Intramuscular Glucagon in Pediatric Growth Hormone Deficiency and Idiopathic Short Stature: What is the risk of hypoglycemia?
hrp0098p2-142
Retrospective Analysis of Early Growth Patterns in Children Diagnosed with Growth Hormone Deficiency
hrp0098p2-143
Growth Aberrations in a Yemeni Girl with Elevated IGF-1 Due to a PAPPA2 Gene Mutation: A Case Report
hrp0098p2-144
Comparison of growth hormone therapy response according to the presence of growth hormone deficiency in short stature children born small for gestational age in Korea
hrp0098p2-145
Clinical characteristics and treatment efficacy evaluation in Lithuanian cohort patients with severe primary IGF-1 deficiency
hrp0098p2-146
Is somatotropin therapy lowering the risk of SARS-CoV-2 infection in children with growth hormone deficiency and idiopathic short stature?
hrp0098p2-147
The Diagnostic Effectiveness of Low IGF-1 Combined with a Single Insulin Tolerance Test for the Diagnosis of Growth Hormone Deficiency
hrp0098p2-148
Real-world experience of using Long-Acting Growth Hormone Somatrogon in children and adolescents with growth hormone deficiency
hrp0098p2-149
Real-world data on growth hormone therapy adherence using a connected injection device and catch-up growth in children with growth disorders in Serbia
hrp0098p2-150
Quality of Life and Treatment Burden of Greek children and adolescents with growth hormone deficiency
hrp0098p2-151
Successful Treatment of increasing chronic Hypoglycaemia by long acting GH a 15y old girl with reduced GH Secretion
hrp0098p2-152
Evaluation of minutes related to the maximum levels and random basal levels of growth hormone during stimulation test with glucagon
hrp0098p2-153
Two Clinical Cases of Growth Hormone Insensitivity Overlapping Disorders: STAT3 Gain-Of-Function Syndrome and Meier-Gorlin Syndrome
hrp0098p2-154
Short and long-term response to rhGH therapy in short children born at very low birth weight
hrp0098p2-155
Dosage of recombinant human growth hormone across geographic regions at enrolment into the Kabi/Pfizer International Growth Study (KIGS)
hrp0098p2-156
Investigation of Short Stature in a 10-Year-Old Girl with STAT3 Gain-of-Function Syndrome
hrp0098p2-157
Healthcare professional (HCP) perceptions towards Mallya® Connectivity Cap & App for long-acting growth hormone: results from a Slovenia Participatory Study
hrp0098p2-158
Growth and Syndromes
Correlation Patterns in Longitudinal Growth of Preterm AGA Infants with Birth Weight < 1.5 kg Over Five Years
hrp0098p2-159
Early Growth Decline in Children with Growth Hormone Deficiency: A Comparative Study with Emphasis on Rapid Catch-Down Growth during early infancy
hrp0098p2-160
Long-Term Effects of Estrogen and Growth Hormone Replacement on Mortality and Comorbidities in Turner Syndrome
hrp0098p2-161
Leptin, ghrelin, and nesfatin-1 in children born small for gestational age with catch up growth
hrp0098p2-162
Noonan Syndrome: About 21 cases
hrp0098p2-163
Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy and literature review
hrp0098p2-164
Pattern of growth and pubertal development in a patient with MIRAGE syndrome
hrp0098p2-165
Corticotropin-Independent Cushing's Syndrome in a 6-Year-Old Girl Treated with Bilateral Adrenal Radiofrequency Ablation
hrp0098p2-166
Kenny - Caffey syndrome type 2 - uncommon cause of short stature
hrp0098p2-167
Pediatric Floating-Harbor Syndrome: Clinical Features and Treatment Outcomes in a Cohort of Chinese Children
hrp0098p2-168
Students in Turkey show a continuing positive secular change of height but a worrying increase of overweight in males
hrp0098p2-169
Assessment of Growth Hormone and Gonadotropin-releasing hormone analog combined treatment in patients with Silver-Russell syndrome
hrp0098p2-170
Development and validation of a deep learning algorithm for predicting vitamin D deficiency risk in children using routine laboratory tests
hrp0098p2-171
European Achondroplasia Forum: Are Current Outcome Measures for Achondroplasia Still Fit for Purpose in the Era of Medical Management?
hrp0098p2-172
Prevalence and changes in genetic and clinical abnormalities in growth hormone-treated girls with Turner syndrome: a study from the Belgian-Luxembourgish growth hormone registry (BELGROW)
hrp0098p2-173
A Chinese case report of X-linked acrogigantism caused by Xq26.3 microduplication
hrp0098p2-174
Endocrinopathy in patients with Prader-Willi syndrome: A single center cohort study
hrp0098p2-175
What is The Most Effective Method for Predicting Adult Height in Boys with Constitutional Delay of Growth and Puberty?
hrp0098p2-176
Gastrointestinal symptoms in adolescents and adults with Silver-Russell syndrome
hrp0098p2-177
Co-Occurrence of DNET and Lymphoma in a patient with Noonan syndrome and mutation in PTPN11 gene
hrp0098p2-178
An Uncommon Cause of Short Stature: 18q Deletion
hrp0098p2-179
A Rare Case of Short Stature and Hypergonadotropic Hypogonadism: LIG4 Mutation
hrp0098p2-180
Mimicking the diagnosis - new challenge for pediatric endocrinology?
hrp0098p2-181
Assessment of the life quality of children experiencing growth retardation
hrp0098p2-182
Growth disorders and endocrine problems in children with FASD
hrp0098p2-183
Impact of Growth Hormone Therapy in Small for Gestational Age (SGA)
hrp0098p2-184
A clinical follow-up of 46 Algerian patients with Prader Willi-Syndrome and their endocrine profile
hrp0098p2-185
“Aggrecan mutation in amidst of congenital neuropathy: what is the relevance of an early genetic diagnosis?”
hrp0098p2-186
Chronic autoimmune thyroiditis and Say- Barber -Biesecker- Young- Simpson syndrome: description of a case of unusual association
hrp0098p2-187
A patient with Rahman syndrome presenting with a novel pathogenic mutation and diabetes
hrp0098p2-188
A child with cutaneous-skeletal hypophosphatemia syndrome caused by a mosaic HRAS mutation – outcome of treatment with anti-FGF23 antibody
hrp0098p2-189
Rare Cases of Primary Hypoparathyroidism in Childhood in the Covid-19 Era
hrp0098p2-190
Many faces of Noonan Syndrome - four case reports
hrp0098p2-191
Assessment of the rhGH treatment compliance in children based on data from centres in Poland and Italy
hrp0098p2-192
Impact of Growth hormone therapy in a Child with SOX3 mutation: A Case Study
hrp0098p2-193
Effectiveness of therapy with recombinant human growth hormone (rhGH) in patients with HLHS and short stature
hrp0098p2-194
Severe intrauterine growth retardation and diagnosis of growth hormone deficiency as initial presentation of TEMPLE syndrome
hrp0098p2-195
Early life growth patterns in cystic fibrosis in Infants from western Algeria
hrp0098p2-196
Adult height of children born small for gestational age treated with growth hormone in southern Brazil
hrp0098p2-197
Multisystem Endocrine Disorders
A Correlation Study Between Iron Overload, Chelation Therapy (ICT), and Metabolic Outcomes in β-Thalassemia Major (β-TDT) Patients
hrp0098p2-198
Impact of Iron Chelation Therapy Adherence on Prediabetes Development in Young Adult β-Thalassemia Major Patients: A Comparative Analysis
hrp0098p2-199
Pseudoprecocious puberty and gynaecomastia as presenting features of Peutz-Jeghers Syndrome
hrp0098p2-200
Assessment of genotype-phenotype correlation in children with pseudohypoparathyroidism
hrp0098p2-201
Endocrine Abnormalities and Growth Pattern in Single Large-Scale Mitochondrial DNA Deletion Syndromes
hrp0098p2-202
Hyperthyroidism and type 1 diabetes mellitus in a girl with down syndrome
hrp0098p2-203
Prevelance of endocrine disorders in thalasemic children and adolescents receiving regular blood transfusion
hrp0098p2-204
Congenital disorders of glycosylation (CDG): Endocrinological features in a case of twin siblings with a
ALG1
gene defect
hrp0098p2-205
A Case of Pediatric PTEN Hamartoma Tumor Syndrome Presenting with a Breast Mass
hrp0098p2-206
Endocrinological disturbances in patients with ROHHAD syndrome- single center data
hrp0098p2-207
A Case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency
hrp0098p2-208
Acute renal failure as first presentation of APECED in infancy
hrp0098p2-209
Endocrine Phenotypic Variability in Schaaf-Yang Syndrome: Insights from a Case Series
hrp0098p2-210
Pituitary, Neuroendocrinology and Puberty
Impact of GNRH analog therapy on early and fast puberty girls: clinical, radiological and hormonal analysis
hrp0098p2-211
Does precocious puberty and its treatment causes the emotional and behavioral problems in children?
hrp0098p2-212
Saliva sex-hormones as an alternative method for assessment of pubertal status
hrp0098p2-213
Hypersensitivity Reactions to Gonadotropin-releasing Hormone Analogue in Children
hrp0098p2-214
Transition-loop, an educational tool that helps to provide a smooth transition to adult care for the youngster with chronic conditions. “Before transition from adolescent care to adult care - necessary considerations”
hrp0098p2-215
The comparison of the timing of menarche in girls with central precocious puberty following the discontinuation of monthly and 3-monthly Leuprolide acetate
hrp0098p2-216
Multihormonal Pituitary Insufficiency as a Late Manifestation of Traumatic Pituitary Stalk Interruption
hrp0098p2-217
Report of a patient with TUBB3 E410K syndrome: when ‘Moebius syndrome’ does not quite fit
hrp0098p2-218
Adult height in girls with idiopathic central precocious puberty with gonadotropin-releasing hormone agonist and recombinant human growth hormone treatment: a retrospective study
hrp0098p2-219
Association between Attention Deficit Hyperactivity Disorder, Precocious Puberty and Obesity in Korean girls
hrp0098p2-220
Central precocious puberty: from etiologies to outcomes in patients at the vietnam national children’s hospital
hrp0098p2-221
Genetic and clinical heterogenicity in Russian adolescents with congenital isolated hypogonadotropic hypogonadism
hrp0098p2-222
Surgical Treatment and Somatostatin Experience in Growth Hormone-Secreting Pituitary Macroadenoma Due to AIP Mutation
hrp0098p2-223
Successful Experience with Tolvaptan in Syndrome of Inappropriate Secretion of Antidiuretic Hormone
hrp0098p2-224
Description of a cohort of paediatric patients with congenital hipopytuitarism
hrp0098p2-225
A High Rate of abnormal Cranial MRI in Saudi Girls with Central Precocious Puberty: Single Center Experience
hrp0098p2-226
Real Life Efficacy and Safety of Monthly (4-week) and 6-Monthly (24-week) Formulations of Gonadotropin-Releasing Hormone Agonist (GnRHa) Among Children with Central Precocious and Early Fast Puberty
hrp0098p2-227
Can Hypophysitis Mask Pituitary Stalk Germinoma? Insights from a Case Series Analysis
hrp0098p2-228
Prevalence of neuropsychiatric symptoms in children with central precocious puberty with or without central nervous system lesions
hrp0098p2-229
Advancing Endocrine Disorder Diagnosis in Cyprus: The Cyprus Institute of Neurology and Genetics as an ENDO-ERN Reference Center
hrp0098p2-230
Pituitary hypoplasia and Growth hormone deficiency in A patient with Baraitser- Winter syndrome
hrp0098p2-231
A Rare Cause of Ovarian Failure: Transaldolase Deficiency
hrp0098p2-232
Novel GLI2 Mutation in a Girl with mild holoprosencephaly presenting with Pituitary Stalk Interruption Syndrome, Central diabetes insipidus and combined pituitary hormone
hrp0098p2-233
Cranberry as a Cause of Premature Menarche
hrp0098p2-234
A rare case of hypogonadotropic hypogonadism associated with skeletal anomalities: ulnar-mammary syndrome
hrp0098p2-235
Achieving normal near final height in girls with idiopathic central precocious puberty and early puberty following gonadotropin-releasing hormone analog treatment: Predictors
hrp0098p2-236
Central Precocious Puberty in Three Sisters with an MKRN3 Gene Variant
hrp0098p2-237
Vaginal Bleeding in a Severely Premature Infant During the Mini-Puberty Period
hrp0098p2-238
Clinical Follow-Up of a Case Diagnosed with POMC Deficiency Presenting with Hypoglycemia and Cholestasis
hrp0098p2-239
Serum MKRN3 levels in girls with central precocious puberty due to MKRN3 loss-of-function mutation
hrp0098p2-240
Sellar Mass Confused with Craniopharyngioma: Mature Cystic Teratoma
hrp0098p2-241
Single Centre Experience in the Management of Childhood Prolactinoma
hrp0098p2-242
Overweight and obesity in children and young people with CNS tumours
hrp0098p2-243
Rapidly progressing peripheral precocious puberty due to pineal germ cell tumor in a preschool age boy
hrp0098p2-244
Effectiveness of the uterine artery pulsatility index as a non-invasive diagnostic method for precocious puberty and its correlation with pelvic and breast ultrasound findings, bone age, and hormonal profile